MedCity News April 15, 2025
Click Therapeutics’ migraine mobile app may now be used alongside standard drug therapies as a way to prevent episodic migraine in adults. In clinical trials, daily use of the app led to a statistically significant reduction in monthly migraine days.
Drugs have been the standard migraine treatment for decades. The severe headaches, nausea, and other problems associated with this common disorder now have a digital treatment option, a mobile app developed by prescription digital medicines developer Click Therapeutics.
The FDA marketing authorization announced Tuesday permits use of the Click digital therapeutic for the prevention of episodic migraine in patients age 18 and older. Episodic migraine is defined as having fewer than 15 headache days per month. The Click migraine app,...
Today's Sponsors
Today's Sponsor